18.95
price up icon5.28%   0.95
after-market Dopo l'orario di chiusura: 18.63 -0.32 -1.69%
loading

Urogen Pharma Ltd Borsa (URGN) Ultime notizie

pulisher
06:04 AM

UroGen Pharma Ltd. Stock Analysis and ForecastExponential wealth increase - PrintWeekIndia

06:04 AM
pulisher
02:10 AM

What analysts say about UroGen Pharma Ltd. stockFree Wealth Planning Blueprint - PrintWeekIndia

02:10 AM
pulisher
07:53 AM

Is UroGen Pharma Ltd. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia

07:53 AM
pulisher
Jul 24, 2025

UroGen Pharma Ltd. (NASDAQ:URGN) Is Expected To Breakeven In The Near Future - Yahoo Finance

Jul 24, 2025
pulisher
Jul 22, 2025

What drives UroGen Pharma Ltd. stock priceFree Risk Assessment Services - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

UROGEN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

UROGEN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds UroGen Pharma (URGN) Investors of the July 28th Deadline and Urges Investors to Inquire About Their Rights in Class Action Lawsuit - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 21, 2025

UroGen Pharma Announces Data Of Phase 2b Of Bladder Cancer Study - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

UroGen Pharma (URGN) Reports Long-term Results for Bladder Cance - GuruFocus

Jul 21, 2025
pulisher
Jul 21, 2025

UroGen’s bladder cancer drug shows durable response in long-term study - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

UroGen Pharma Announces Long-Term Efficacy Results of ZUSDURI for Non-Muscle Invasive Bladder Cancer in Clinical Genitourinary Cancer Journal - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

UroGen Announces Five-Year Long-Term Extension Study of the - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Breakthrough: New Bladder Cancer Treatment Maintains Effectiveness for 3.5 Years Without Surgery - Stock Titan

Jul 21, 2025
pulisher
Jul 20, 2025

2025-07-20 | URGN Shareholders Have Opportunity to Lead UroGen Pharma Ltd. Class Action LawsuitContact Bronstein, Gewirtz and Grossman, LLC Today! | NDAQ:URGN | Press Release - Stockhouse

Jul 20, 2025
pulisher
Jul 19, 2025

UROGEN ALERT: Bragar Eagel & Squire, P.C. Urges Investors - GlobeNewswire

Jul 19, 2025
pulisher
Jul 19, 2025

Urogen Pharma (NASDAQ:URGN) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

UroGen Bets Big On Gel-Based Cancer Treatments - Finimize

Jul 18, 2025
pulisher
Jul 17, 2025

URGN Class Action News: UroGen Pharma Ltd. Investors with - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

2025-07-17 | URGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that UroGen Pharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:URGN | Press Release - Stockhouse

Jul 17, 2025
pulisher
Jul 16, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UroGen Pharma Ltd. of Class Action Lawsuit and Upcoming DeadlinesURGN - ETX View

Jul 16, 2025
pulisher
Jul 16, 2025

What makes UroGen Pharma Ltd. stock price move sharplyBreakout Setup Scanner - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

UROGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors - GlobeNewswire

Jul 15, 2025
pulisher
Jul 14, 2025

2025-07-14 | URGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that UroGen Pharma Ltd. Investors Have Opportunity to Lead Class Action Lawsuit! | NDAQ:URGN | Press Release - Stockhouse

Jul 14, 2025
pulisher
Jul 13, 2025

What UroGen Pharma Ltd.'s (NASDAQ:URGN) 84% Share Price Gain Is Not Telling You - 富途牛牛

Jul 13, 2025
pulisher
Jul 12, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Jul 12, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):